CVE-2026-112177Ghostscript: reintroduction of .charkeys -dsafer bypass in rhel 8
Updated under an hour ago ()
Does this affect you?
It affects Red Hat Enterprise Linux 10. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.26%, higher than 17% of scored CVEs.
Do this next
Free account, 1 product
A flaw was found in Ghostscript as shipped with Red Hat Enterprise Linux 8. The correction for CVE-2019-14869 was omitted during the rebase from version 9.25 to 9.27, leaving privileged .forceput operations in the .charkeys procedure insufficiently protected. Processing a specially crafted PostScript file may allow an attacker to bypass -dSAFER restrictions and access files outside the permitted paths or execute commands with the permissions of the Ghostscript process.
- CVSS
- 7.3 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
- Weakness (CWE)
- CWE-648
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.26% (percentile 17)
- Assigned by
- redhat
- NVD analysis
- Awaiting Analysis
- Record last updated
- Oct 20, 2026
- First seen by InfoSec Signals
- Oct 20, 2026
Affected products
Red Hat Red Hat Enterprise Linux 10 redhat:enterprise_linux | 10 | CNA record |
References
- https://access.redhat.com/security/cve/CVE-2026-112177vdb-entry, x-refsource-redhat
- https://bugzilla.redhat.com/show_bug.cgi?id=2555564issue-tracking, x-refsource-redhat
- https://github.com/ArtifexSoftware/ghostpdl/commit/485904772c5f0aa1140032746e5a0abfc40f4cef
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.